Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable | January 17, 2017 | Dave Fornell

One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable...

Frost & Sullivan, 18 technologies, growth opportunities, global healthcare, information technology, 2025
News | Information Technology | January 16, 2017

January 16, 2017 — Frost & Sullivan has released a new report, “Vision 2025 – Future of Healthcare,” part of the...

BioSig Technologies, Pure EP system, JACC Clinical Electrophysiology, Journal of the American College of Cardiology, Purkinje Network
News | EP Mapping and Imaging Systems | January 16, 2017

January 16, 2017 — BioSig Technologies Inc. announced that the company’s Pure EP System, a novel cardiac...

Arterys, Cardiac MRI, cardiac MRI advances

An example of the Arterys blood flow imaging assessment software that can help automate cardiac MRI. 

Feature | Cardiac Imaging | January 16, 2017 | Dave Fornell

Each year imaging system manufacturers use the Radiological Society of North America (RSNA) meeting at the end of...

Tendyne Mitral valve

The Tendyne mitral valve being implanted. 

News | Heart Valve Technology | January 16, 2017

January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the...

BioTrace Medical, first U.S. patients, Tempo Temporary Pacing Lead, EP lab, TAVR
News | Leads Implantable Devices | January 13, 2017

January 13, 2017 — BioTrace Medical Inc. announced in December the first commercial use of the company’s Tempo...

OCT, intravascular imaging, stent, good stent apposition on vessel wall, TRANSFORM-OCT study

An OCT image showing good stent strut apposition against the vessel wall.

News | Stents | January 13, 2017

January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (...

Sponsored Content | Videos | Cardiovascular Ultrasound | January 13, 2017

Detailed imaging is needed to support complex interventions for the assessment and procedure guidance.  See how the...

Xcertia, new alliance, guidelines, mobile health applications
News | Mobile Devices | January 12, 2017

January 12, 2017 — Four organizations have announced they are forming a new, multi-stakeholder collaboration,...

ACIST-FFR Study, enrollment complete, Navvus catheter, fractional flow reserve
News | FFR Catheters | January 12, 2017

January 12, 2017 — Acist Medical Systems Inc. announced that enrollment is complete for its...

updated classification system, heart attack risk, Mount Sinai, Johns Hopkins, Journal of the American College of Cardiology, JACC
News | Cardiac Diagnostics | January 12, 2017

January 12, 2017 — Experts at Johns Hopkins and New York's Mount Sinai Health System have published a suggested new...

GE Healthcare, Vscan Extend, app-based ultrasound, dual-probe, RSNA 2017
Technology | Ultrasound Imaging | January 12, 2017

January 12, 2017 — GE Healthcare unveiled its new generation of pocket-sized, dual-probe...

TrumpCare, 9 ways may change the healthcare industry, Vertess
News | Business | January 12, 2017

January 12, 2017 — International healthcare-focused merger and acquisition (M+A) advisory firm Vertess recently...

EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD

Gregg W. Stone, M.D., presenting the EXCEL data at TCT 2016 during a standing room only late-breaking trial session.

Feature | Stents | January 12, 2017 | Dave Fornell

The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the...

Medrad Intego PET Infusion System, recall
News | Nuclear Imaging | January 12, 2017

January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source...

Overlay Init